Lee H. Kalowski

2015

In 2015, Lee H. Kalowski earned a total compensation of $790.4K as Former Chief Financial Officer at Tokai Pharmaceuticals, a 76% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$46,027
Option Awards$393,454
Salary$320,000
Other$30,936
Total$790,417

Kalowski received $393.5K in option awards, accounting for 50% of the total pay in 2015.

Kalowski also received $46K in non-equity incentive plan, $320K in salary and $30.9K in other compensation.

Rankings

In 2015, Lee H. Kalowski's compensation ranked 9,028th out of 13,638 executives tracked by ExecPay. In other words, Kalowski earned more than 33.8% of executives.

ClassificationRankingPercentile
All
9,028
out of 13,638
34th
Division
Manufacturing
3,442
out of 5,187
34th
Major group
Chemicals And Allied Products
1,257
out of 1,857
32nd
Industry group
Drugs
1,024
out of 1,531
33rd
Industry
Pharmaceutical Preparations
794
out of 1,179
33rd
Source: SEC filing on August 18, 2017.

Kalowski's colleagues

We found four more compensation records of executives who worked with Lee H. Kalowski at Tokai Pharmaceuticals in 2015.

2015

Gerald Quirk

Tokai Pharmaceuticals

General Counsel

2015

Jodie Morrison

Tokai Pharmaceuticals

Chief Executive Officer

2015

John McBride

Tokai Pharmaceuticals

Chief Financial Officer

2015

Karen Ferrante

Tokai Pharmaceuticals

Chief Medical Officer

You may also like